Roivant Sciences Ltd (ROIV) Volatility Spurs A Quest For Clarity
Fidelity Management & Research Co recently announced the acquisition of new stake in Roivant Sciences Ltd (NASDAQ:ROIV). The institutional investor has increased its shareholding in the Healthcare company by 8.10% to 38.88 million shares with purchase of 2.91 million shares. This fresh investment now brings its stake to 4.84% valued currently at $436.66 million. In […]
Roivant Sciences Ltd (NASDAQ: ROIV) Has Another Chance To Impress You
Fidelity Management & Research Co recently announced the acquisition of new stake in Roivant Sciences Ltd (NASDAQ:ROIV). The institutional investor has increased its shareholding in the Healthcare company by 8.10% to 38.88 million shares with purchase of 2.91 million shares. This fresh investment now brings its stake to 4.84% valued currently at $436.66 million. In […]
Roivant Sciences Ltd (NASDAQ: ROIV) Hogging The Spotlight Today
Fidelity Management & Research Co recently announced the acquisition of new stake in Roivant Sciences Ltd (NASDAQ:ROIV). The institutional investor has increased its shareholding in the Healthcare company by 8.10% to 38.88 million shares with purchase of 2.91 million shares. This fresh investment now brings its stake to 4.84% valued currently at $371.72 million. In […]
Growth Story Still Intact For Roivant Sciences Ltd (ROIV)
Fidelity Management & Research Co has recently announced that it has increased stake in Roivant Sciences Ltd (NASDAQ:ROIV) by 8.10%. After grabbing 38.88 million shares, the institutional investor is now in possession of 2.91 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 4.84% having worth around $371.72 […]
